Abstract
Aim: Acalculous cholecystitis (AAC) accounts for only 5-10% of cholecystitis cases, primarily studied in intensive care units (ICU) patients. The aim of this study to identify risk factors and clinical presentation of AAC in non-ICU patients. Material and methods: We conducted a literature review using PubMed MeshTerms “acalculous cholecystitis” and searched our institution’s database (2018-2022) for “cholecystitis” and “acalculous cholecystitis,” including patients with histopathological findings. Results: 23 patients met the inclusion criteria. based on histopathology report and diagnosis. The most common co-morbidities were cardiovascular and metabolic syndrome. Abdominal pain was the predominant complaint. Ten patients (50%) presented with elevated CRP, bilirubin, and leukocytosis. No mortality was reported at 30 days. Conclusion: AAC in outpatients is not associated with high mortality, unlike in ICU settings. However, it is more frequent in polymorbid patients with cardiovascular risk factors.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Clinical Case Reports and Reviews
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
